Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging
Man Hu(Agricultural Genomics Institute at Shenzhen), Yufang Zhu(Shandong University), Tao Xin(Jiangxi Provincial People's Hospital), Xianbin Zhang(Xi'an University of Technology), Jinming Yu(Shandong University), Song Xue(Shanxi Medical University), Jia Yang(Xinjiang Medical University), Yongsheng Gao(Jilin University), Xingchen Ding(Shandong Tumor Hospital), Jujie Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhaoqiu Chen(Shandong Tumor Hospital), Dianbin Mu(Shandong University)
Cited by 10
Related Papers
Biochar supported nanoscale zerovalent iron composite used as persulfate activator for removing trichloroethylene
|Bioresource Technology|2014|600
Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy
|Bioactive Materials|2021|203
Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
|Molecular Cancer|2023|106
Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma
|Oncotarget|2017|99
KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
|Journal of Experimental & Clinical Cancer Research|2018|88